Just to add to the credibility talkI will say one thing, Thtx has not taken on anything that seems to have not worked out as far as r&d. Sales clearly not their strong point but gettting projects to the finish line is definitely very much their forte. After yesterday's pr I felt like all the doubts I had about a lot of where they were headed are put to rest. And like spceo and wino ect have pointed out its only a matter of time before that valuation that we all know is right comes to life. It makes me feel that when they play things so close to the chest ie nash and oncology they already have a good idea of where it's heading. I would say you can back the truck up for any price under double digits this year. Oncology will be a home run as Thtx has proven they don't get involved with a project without feeling extremely confident in the outcome as far as dealing with the agencies. Would be nice to see a better reaction to yesterday but it's on its way. I was always agreeing with everyone saying be patient because I was trying to cling onto some hope for this company because I had such a big position relative to my situation. But now I actually really think that this has a good chance to be one of those 5 chances in the market that a person has to really do some damage. Analysis on this board has been pretty spot on, only a matter of time before they run out of Cheetos and have to do some actual work. 2021 is the breakout